Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02754895 · ClinicalTrials.gov registry record · NA

Positive Psychology for ACS Patients: a Factorial Design Study

A NA study, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
128
Enrollment target

NCT02754895: Completed NA study, sponsored by Massachusetts General Hospital.

NCT02754895 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 128 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02754895, a NA study, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
128 participants
Enrollment target

Study Summary

This trial is part of a multi-phase study to develop and test positive psychology (PP) interventions in patients hospitalized for an acute coronary syndrome (ACS).Using a factorial design, the investigators will: (a) assess the optimal frequency of exercise completion, (b) determine the utility of 'booster sessions' after an initial 8-week intervention, and (c) determine the relative merits of utilizing PP exercises alone versus an intervention combining PP with motivational interviewing (MI).

Primary Outcome

To assess which components of the intervention (daily vs. weekly exercise completion, booster vs. no booster sessions, PP only vs. PP + MI) are associated with the greatest physical activity measured by the Actigraph accelerometer (steps) at 16 weeks.

Interventions

  • OTHER Positive Psychology (PP)
  • OTHER Motivational Interviewing (MI)

Trial Details

FieldValue
Enrollment Target 128 participants
Start Date 2014-10
Est. Completion 2017-05
Phase NA
Massachusetts General Hospital

2,032 total trials

What the finished NCT02754895 record still lists

NCT02754895 is an interventional study that assigns participants to a tested intervention. The registered 128 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).

The record links to 0 conditions, and to 2 interventions - of which Positive Psychology (PP) is the first listed.

NCT02754895 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02754895 about?

NCT02754895 is a clinical study titled "Positive Psychology for ACS Patients: a Factorial Design Study". This trial is part of a multi-phase study to develop and test positive psychology (PP) interventions in patients hospitalized for an acute coronary syndrome (ACS).Using a factorial design, the investigators will: (a) assess the optimal frequency of exercise completion, (b) determine the utility of '...

What is the current status of trial NCT02754895?

This trial is currently completed. It is a NA study. The enrollment target is 128 participants. The study started on 2014-10. Estimated completion is 2017-05.

What interventions are being tested in trial NCT02754895?

The interventions under investigation include: Positive Psychology (PP) (OTHER), Motivational Interviewing (MI) (OTHER).

Who is sponsoring clinical trial NCT02754895?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02754895's enrollment target sits among peer trials

128 744th of 2000 higher than 1,252 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02870738 · 128 participants · Phase 2

    Bladder Directed vs. Pelvic Floor Therapy in IC/BPS

  • NCT03294460 · 128 participants · Phase 1

    Nicotinic Receptor Genetic Variation and Alcohol Reward

  • NCT04149977 · 128 participants · NA

    Blood Flow Restriction Therapy in Lower Limb Extensor Injuries

  • NCT04373057 · 128 participants · Phase 1

    Prebiotic Galacto-oligosaccharide and Acute GVHD

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02754895, the US trial registry maintained by the National Library of Medicine. NCT02754895 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.